Although autoantibody profiling has enhanced risk stratification and informed cancer screening strategies in DM, substantial therapeutic challenges remain.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Proximal weakness and elevated creatine kinase were ...

Classic DM (CDM) presents with pathognomonic cutaneous findings and progressive, symmetric proximal muscle weakness. Cutaneous disease usually precedes the appearance of myositis by 3–6 months in ...

History gathering should solicit the patient’s abilities or limitations with these activities of daily living (ADLs). The patient may have mild arthralgias. Lungs are the most common extra muscular ...